Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-09-09

FDA Approved: GLUCAGON — Supplemental Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

The FDA approved a supplemental application for GLUCAGON submitted by Fresenius Kabi USA, LLC. The approval updates labeling and/or administration details for G…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GLUCAGON (GLUCAGON)

Snippet

SUPPL AP for GLUCAGON (GLUCAGON)